Post
Clinical Trials Arena Excellence Awards 2023: ProofPilot
ProofPilot is a New York based software company that provides clinical trial automation for drug development. The company is a …
Pfizer and Arvinas plan vepdegestrant programme expansion after data at SABCS
Pfizer and Arvinas are broadening their vepdegestrant programme to include more settings, as positive data is reported from the Phase …
New CDC data shows rebound in US life expectancy
For almost half a decade, trends showing a decline in US life expectancy have been the objects of surprise and …
Micro Medical completes enrollment for stent pivotal trial
Micro Medical has completed enrolment for a US pivotal clinical study evaluating the safety and effectiveness of its MicroStent system …
Vesper Bio doses first patient in Phase I frontotemporal dementia trial
Danish biotech firm Vesper Bio has dosed the first participant in the Phase I trial evaluating oral treatment VES001 in …
Armed with Blenrep and a DREAMM, GSK sets its sights on early lines of relapsed/refractory multiple myeloma
Multiple myeloma (MM) is currently the third most prevalent form of blood cancer in the world. Approximately 150,000 people are …
Insilico’s AI-discovered ulcerative colitis drug starts Phase I trial
Hong Kong-based Insilico Medicine has launched a Phase I trial of its artificial intelligence (AI)-discovered drug ISM5411. The Phase I trial …
Strategies and innovations for reducing drug product loss in sterile filling
Sterile filling is a critical step in pharmaceutical primary packaging; the transfer of sterile drug product into its final primary …
Seagen reports positive data on Tukysa from Phase III breast cancer trial
Seagen has reported positive topline data from the Phase III HER2CLIMB-02 clinical trial investigating Tukysa (tucatinib) in combination with the …
Geron completes 50% subject enrolment in Phase III myelofibrosis trial
Geron has completed 50% subject enrolment in the Phase III IMpactMF clinical trial of its telomerase inhibitor, imetelstat, to treat …
Syros reports initial findings from acute myeloid leukaemia trial
Syros Pharmaceuticals has reported encouraging initial findings from its SELECT-AML-1 Phase II clinical trial of tamibarotene plus venetoclax and azacitidine …
Q&A: Dr Christina Yap talks about SPIRIT and CONSORT guidance
The CONSORT2010 guidance is used globally when academics are writing papers on clinical trials, providing a checklist for researchers to …
Delpor on track with schizophrenia implant late-stage trials
Delpor is sketching out late-stage clinical trial plans for its drug-device combination implant DLP-114 (risperidone) in schizophrenia. After presenting topline results …
Anixa and Cleveland Clinic report Phase I breast cancer vaccine data
Anixa Biosciences and Cleveland Clinic in the US have reported positive data from the Phase I clinical trial of breast …
MyMD to begin Phase II trial of rheumatoid arthritis therapy
MyMD Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) application …